{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:45:11Z","timestamp":1793742311131,"version":"4.6.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12902-019-0398-8","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T12:03:18Z","timestamp":1562068998000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Metabolic encephalopathy secondary to diabetic ketoacidosis: a case report"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2562-5210","authenticated-orcid":false,"given":"Maria","family":"Tomkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ine","family":"Merwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"398_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5660","volume":"351","author":"S Misra","year":"2015","unstructured":"Misra S, Oliver NS. Diabetic ketoacidosis in adults. BMJ. 2015;351:h5660.","journal-title":"BMJ"},{"key":"398_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/B978-0-12-407710-2.00060-6","volume-title":"Aminoff\u2019s Neurology and General Medicine","author":"JC Hemphill","year":"2014","unstructured":"Hemphill JC. Chapter 60: Disorders of consciousness in systemic diseases. In: Aminoff M, Josephson SA, editors. Aminoff\u2019s Neurology and General Medicine. 5th ed. San Diego: Academic Press; 2014. p. 1243\u201361.","edition":"5"},{"key":"398_CR3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/B978-075067572-7.50040-0","volume-title":"Cardiothoracic critical care","author":"J Beca","year":"2007","unstructured":"Beca J, Sidebotham D. Chapter 37: neurologic dysfunction. In: Sidebotham D, McKee A, Gillham M, Levy J, editors. Cardiothoracic critical care. Oxford: Butterworth-Heinemann; 2007. p. 548\u201362."},{"key":"398_CR4","first-page":"351","volume":"42","author":"V Supanc","year":"2003","unstructured":"Supanc V, Vargek-Solter V, Demarin V. Metabolic encephalopathies. Acta Clin Croat. 2003;42:351\u20137.","journal-title":"Acta Clin Croat"},{"issue":"2","key":"398_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/pdi.1450","volume":"27","author":"AD Miras","year":"2010","unstructured":"Miras AD, Ward H. Encephalopathy following diabetic ketoacidosis in a type 1 diabetes patient. Practical Diabetes Int. 2010;27(2):76\u20138.","journal-title":"Practical Diabetes Int"},{"issue":"7","key":"398_CR6","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.2337\/db11-1286","volume":"61","author":"N Glaser","year":"2012","unstructured":"Glaser N, Ngo C, Anderson S, Yuen N, Trifu A, O\u2019Donnell M. Effects of hyperglycemia and effects of ketosis on cerebral perfusion, cerebral water distribution and cerebral metabolism. Diabetes. 2012;61(7):1831\u20137.","journal-title":"Diabetes"},{"issue":"1","key":"398_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4239\/wjd.v6.i1.167","volume":"6","author":"SR Biao","year":"2015","unstructured":"Biao SR, Agrawal S, Boney CM, Quintos JB. Rare complications of pediatric diabetic ketoacidosis. World J Diabetes. 2015;6(1):167\u201374.","journal-title":"World J Diabetes"},{"issue":"2","key":"398_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/1753-0407.12448","volume":"9","author":"K Siwakoti","year":"2017","unstructured":"Siwakoti K, Giri S, Kadaria D. Cerebral edema among adults with diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome: incidence, characteristics, and outcomes. J Diabetes. 2017;9(2):208\u20139.","journal-title":"J Diabetes"},{"issue":"3","key":"398_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4274\/jcrpe.2158","volume":"7","author":"AB Jessup","year":"2015","unstructured":"Jessup AB, Grimley MB, Meyer E, Passmore GP, Belger A, Hoffman WH, Calikoglu AS. Effects of diabetic ketoacidosis on visual and verbal neurocognitive function in young patients presenting with new-onset type 1 diabetes. J Clin Res Pediatr Endocrinol. 2015;7(3):203\u201310.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"398_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.brainres.2010.10.085","volume":"1369","author":"WH Hoffman","year":"2011","unstructured":"Hoffman WH, Siedlak SL, Wang Y, Castellani RJ, Smith M. Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis. Brain Res. 2011;1369:194\u2013202.","journal-title":"Brain Res"},{"issue":"5","key":"398_CR11","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180660","volume":"38","author":"X Zhao","year":"2018","unstructured":"Zhao X, Han Q, Gang X, Wang G. Altered brain metabolites in patients with diabetes mellitus and related complications \u2013 evidence from the 1H MRS study. Biosci Rep. 2018;38(5):BSR20180660.","journal-title":"Biosci Rep"},{"key":"398_CR12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/jnnp.72.5.567","volume":"72","author":"EH Reynolds","year":"2002","unstructured":"Reynolds EH. Benefits and risks of folic acid in the nervous system. J Neurol Neurosurg Psychiatry. 2002;72:567\u201371.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"398_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/NRL.0b013e3182173528","volume":"17","author":"DW Kim","year":"2011","unstructured":"Kim DW, Moon Y, Gee Noh H, Choi JW, Oh J. Blood-brain barrier disruption is involved in seizure and hemianopsia in nonketotic hyperglycemia. Neurologist. 2011;17(3):164\u20136.","journal-title":"Neurologist"},{"key":"398_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.nicl.2013.12.001","volume":"4","author":"SP Cramer","year":"2014","unstructured":"Cramer SP, Simonsen H, Frederiksen JL, Rostrup E, Larsson HBW. Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI. Neuroimage Clin. 2014;4:182\u20139.","journal-title":"Neuroimage Clin"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-019-0398-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12902-019-0398-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-019-0398-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T23:55:51Z","timestamp":1593561351000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-019-0398-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["398"],"URL":"https:\/\/doi.org\/10.1186\/s12902-019-0398-8","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"23 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent to publish the patient\u2019s personal data was obtained from the patient\u2019s next of kin and family. A copy of written consent is available for review by the Editor of this journal.This manuscript was developed with adherence to the CARE guidelines and methodology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Amar Agha is a member of the editorial board (Section Editor) of BMC Endocrine Disorders. All other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}